CEVA CCO granted 17,793 restricted stock units

Toquet Gweltaz reported acquisition or exercise transactions in this Form 4 filing.

Rhea-AI Filing Summary

Toquet Gweltaz reported acquisition or exercise transactions in this Form 4 filing.

CEVA Inc.'s Chief Commercial Officer, Gweltaz Toquet, received a grant of 17,793 shares of common stock in the form of restricted stock units at a price of $0.0000 per share on February 19, 2026. These RSUs are scheduled to vest 33.4% on February 19, 2027, 33.3% on February 19, 2028, and 33.3% on February 19, 2029 under the company’s 2011 Equity Incentive Plan. Following this award, Toquet’s direct holdings total 74,156 shares, consisting of 36,100 shares outstanding and 38,056 unvested RSUs.

Insider Trade Summary

Grant/Award: 17,793 shares

Grant/Award 1 txn

Insider Toquet Gweltaz

Role Chief Commercial Officer

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	17,793	$0.00	$0.00

Holdings After Transaction: Common Stock — 74,156 shares (Direct)

Footnotes (2)

1. F1. Represents shares subject to restricted stock units (RSUs). The RSU grant will vest 33.4% on February 19, 2027, 33.3% on February 19, 2028 and 33.3% on February 19, 2029. The RSU award was made pursuant to the Corporation's 2011 Equity Incentive Plan.
2. F2. Represents 36,100 shares outstanding and 38,056 unvested RSU's.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did CEVA (CEVA) disclose about Gweltaz Toquet’s latest equity award?

CEVA disclosed that Chief Commercial Officer Gweltaz Toquet received 17,793 restricted stock units on February 19, 2026. The award was granted at zero cost per share under the company’s 2011 Equity Incentive Plan as part of his equity-based compensation package.

How do the new RSUs for CEVA’s Gweltaz Toquet vest over time?

The 17,793 RSUs granted to CEVA’s Chief Commercial Officer vest in three tranches: 33.4% on February 19, 2027, 33.3% on February 19, 2028, and 33.3% on February 19, 2029. This schedule encourages longer-term retention and alignment with shareholder interests.

What is Gweltaz Toquet’s total CEVA share exposure after this Form 4 filing?

After the grant, Gweltaz Toquet holds 74,156 CEVA common shares in total. This includes 36,100 shares outstanding and 38,056 unvested restricted stock units, reflecting both currently owned stock and future potential share delivery subject to vesting conditions.

What equity plan was used for Gweltaz Toquet’s CEVA restricted stock grant?

The RSU award to CEVA’s Chief Commercial Officer was made under the company’s 2011 Equity Incentive Plan. Equity incentive plans typically authorize share-based compensation, such as RSUs and options, to align executives’ interests with long-term company performance and shareholder value.

Did Gweltaz Toquet buy or sell CEVA shares in this Form 4 transaction?

The Form 4 reports an acquisition through a grant or award, not an open-market buy or sale. Toquet received 17,793 CEVA restricted stock units at no cash cost as part of his compensation, increasing his total equity-based holdings in the company.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 02/23/2026 - 04:08 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Toquet Gweltaz

(Last) (First) (Middle)

CEVA, INC.

15245 SHADY GROVE ROAD, SUITE 400

(Street)

ROCKVILLE MD 20850

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
CEVA INC [ CEVA ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Commercial Officer

3. Date of Earliest Transaction (Month/Day/Year)
02/19/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	02/19/2026		A		17,793(1)	A	$0	74,156(2)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents shares subject to restricted stock units (RSUs). The RSU grant will vest 33.4% on February 19, 2027, 33.3% on February 19, 2028 and 33.3% on February 19, 2029. The RSU award was made pursuant to the Corporation's 2011 Equity Incentive Plan.

2. Represents 36,100 shares outstanding and 38,056 unvested RSU's.

	/s/ Gweltaz Toquet	02/23/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.